Navigation Links
Biodel Reports Research Progress in Poster Session on Short-Acting Insulins at 46th EASD Annual Meeting
Date:9/23/2010

DANBURY, Conn., Sept. 23 /PRNewswire/ -- Biodel Inc. (Nasdaq: BIOD) today reported recent findings from the company's diabetes drug research program during a poster session on short-acting insulins at the 46th annual meeting of the European Association for the Study of Diabetes in Stockholm.

In the first poster presentation, "Biocompatibility of the ultra-rapid insulin VIAject® (Linjeta™) with continuous insulin infusion sets," Dr. Frank Flacke of Biodel reported that Linjeta™ was pharmacologically stable under conditions simulating continuous subcutaneous insulin infusion.  Linjeta™ is Biodel's more-rapid-acting insulin formulation currently under review by the U.S. Food and Drug Administration.  The study found that after a four-day infusion simulation, the composition, degradation products and molecular weight of Linjeta™ were comparable to a reference sample stored under similar conditions.  The investigators concluded that Linjeta™ was compatible with several commercially available insulin pump infusion sets and a viable candidate for pump delivery.  

In the second poster presentation, "Pharmacokinetics of novel formulations of insulin analogs providing a more rapid onset of action in the diabetic swine model," Dr. Roderike Pohl and colleagues from Biodel reported that reformulations of three insulin analogs – insulin lispro, insulin aspart and insulin glulisine – with excipients used in Linjeta™ increased their rates of absorption and elimination in eight miniature diabetic swine.  The authors concluded that these rapid-acting insulin analogs may be reformulated to enable their faster absorption, more precise mealtime administration and better use in controlling post-prandial blood glucose.  

Abstracts summarizing these presentations are available on Biodel's website, '/>"/>

SOURCE Biodel Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Biodel Appoints Arthur Urciuoli to its Board of Directors
2. Biodel to Raise $9.4 Million Through Registered Direct Offering
3. Biodel Announces Schedule for Presentations at the 37th Annual Meeting and Exposition of the Controlled Release Society
4. Biodel Inc. Announces the Completion of Its Two Pivotal Trials and the Release of EASD Abstracts Containing Additional Interim Data From Its VIAject(TM) Program
5. Biodel Inc. Completes Enrollment of Two Pivotal Phase III Clinical Trials of VIAject(TM) and Plans Manufacturing Facility for VIAject(TM)
6. Biodel Inc. Expands Ongoing Phase III VIAject(TM) Clinical Trials Into Europe
7. Elsevier Launches International Journal of Surgery Case Reports
8. J.D. Power and Associates Reports: As Consumers Shoulder More Healthcare Expenses, Cost Increasingly Drives Overall Customer Satisfaction With Pharmacies
9. 12-Month Study Reports Efficacy Rates for AMS Elevate Apical and Posterior Prolapse Repair System
10. ChemoCentryx Reports Positive Results and Completion of Phase I Clinical Studies of Novel CCR2 Antagonist, CCX140, at the European Association for the Study of Diabetes (EASD)
11. Cyberonics Reports Inducement Equity Awards Under NASDAQ Listing Rule 5635(c)(4)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/4/2015)... MADISON HEIGHTS, Mich. , March 4, 2015 /PRNewswire/ ... national provider of infusion pumps and related services for ... issue fourth quarter and full year 2014 financial results ... The Company will also conduct a conference ... 4:30 p.m. Eastern Time to discuss fourth quarter and ...
(Date:3/4/2015)... WASHINGTON , March 4, 2015  Mail-service ... consumers, employers and government health plans ... research released by the Pharmaceutical Care Management Association ... specialty drugs offers one of the easiest ways ... CEO Mark Merritt . "Policymakers should resist ...
(Date:3/4/2015)... , March 4, 2015   Mayo Clinic ... agreement to develop the next generation of wearable biosensors ... are hoping that this technology will be game-changer. These ... diabetes," says James Levine, M.D., Ph.D. , a ... are accurate, inexpensive, and can be integrated into the ...
Breaking Medicine Technology:PCMA: Report Shows High-Tech Specialty and Mail-Service Pharmacies Will Reduce Costs for Illinois Employers, Consumers and Public Programs by $11.8 Billion 2Mayo Clinic and Gentag, Inc. Announce Agreement To Develop Wireless Sensors for Treatment of Obesity and Diabetes 2Mayo Clinic and Gentag, Inc. Announce Agreement To Develop Wireless Sensors for Treatment of Obesity and Diabetes 3
... Accuray Incorporated (Nasdaq: ARAY ), a global ... accepted abstracts highlighting the use of the CyberKnife Robotic Radiosurgery ... 52nd Annual Meeting of the American Society for Radiation Oncology ... Presentations related to CyberKnife radiosurgery cover a ...
... HSIC ), the largest provider of healthcare products ... for the quarter ended September 25, 2010. Net ... an increase of 14.1% compared with the third quarter of ... a decline of 2.3% related to foreign currency exchange.  Internal ...
Cached Medicine Technology:Accuray's CyberKnife VSI System Featured at 2010 American Society for Radiation Oncology (ASTRO) Annual Meeting 2Accuray's CyberKnife VSI System Featured at 2010 American Society for Radiation Oncology (ASTRO) Annual Meeting 3Accuray's CyberKnife VSI System Featured at 2010 American Society for Radiation Oncology (ASTRO) Annual Meeting 4Henry Schein Reports Record Third Quarter Results 2Henry Schein Reports Record Third Quarter Results 3Henry Schein Reports Record Third Quarter Results 4Henry Schein Reports Record Third Quarter Results 5Henry Schein Reports Record Third Quarter Results 6Henry Schein Reports Record Third Quarter Results 7Henry Schein Reports Record Third Quarter Results 8Henry Schein Reports Record Third Quarter Results 9Henry Schein Reports Record Third Quarter Results 10Henry Schein Reports Record Third Quarter Results 11
(Date:3/4/2015)... (PRWEB) March 04, 2015 Dr. Christopher ... NuMale Medical Center today lamented the FDA’s recent ... therapy (TRT). He argued that FDA’s conclusions are ... harm men who suffer from testosterone deficiency. , “The ... equivocation” on testosterone replacement therapy,” said Dr. Asandra. “There ...
(Date:3/4/2015)... Austria (PRWEB) March 04, 2015 ... reduce subjectivity in density assessment and help improve ... of numerous abstracts accepted for presentation at the ... 2015. Ten abstracts - eight posters and ... Volpara Solutions’ automated breast density and quantitative breast ...
(Date:3/4/2015)... 2015 Starting February 2015, Dr. Joseph ... procedures at their new location in Surrey. , In ... and Dr. Gabriel Chu also provide comprehensive ophthalmology services, ... named Fraser Valley Cataract and Laser (FVCL). This state ... College of Physicians and Surgeons of British Columbia. Fraser ...
(Date:3/4/2015)... Georgia (PRWEB) March 04, 2015 State ... part of the School of Public Health at Georgia ... The funds were awarded by Georgia’s Division of Family ... to support the DFCS Call Center. , The ... maltreatment by providing information and referral services that promote ...
(Date:3/4/2015)... La Farge, Wis. (PRWEB) March 04, 2015 ... a leading organic brand, today announced its cause campaign to ... has gone viral and is making a difference to Bros ... million views on Youtube and Facebook. The video was ... and was featured in Forbes, Mashable and Digiday, among other ...
Breaking Medicine News(10 mins):Health News:NuMale’s Dr. Christopher Asandra: FDA Suffering from “Premature Equivocation” on Issue of Testosterone and Risks 2Health News:Research Finds Use of Volpara Solutions’ Quantitative Breast Imaging Tools Help Reduce Subjectivity in Density Assessment and Improve Breast Cancer Risk Prediction 2Health News:Research Finds Use of Volpara Solutions’ Quantitative Breast Imaging Tools Help Reduce Subjectivity in Density Assessment and Improve Breast Cancer Risk Prediction 3Health News:Research Finds Use of Volpara Solutions’ Quantitative Breast Imaging Tools Help Reduce Subjectivity in Density Assessment and Improve Breast Cancer Risk Prediction 4Health News:Research Finds Use of Volpara Solutions’ Quantitative Breast Imaging Tools Help Reduce Subjectivity in Density Assessment and Improve Breast Cancer Risk Prediction 5Health News:King LASIK relocates to Surrey, British Columbia 2Health News:State Funds Child Abuse Helpline Housed At Georgia State 2Health News:ORGANIC VALLEY URGES PUBLIC TO SAVE THE BROs: CAMPAIGN EARNS MORE THAN 1M VIEWS ON YOUTUBE 2Health News:ORGANIC VALLEY URGES PUBLIC TO SAVE THE BROs: CAMPAIGN EARNS MORE THAN 1M VIEWS ON YOUTUBE 3
... for treatment of Human Immunodeficiency Virus type 1 ... of combination therapy in 1996//. More recently, new ... and improved safety profiles, while some previously popular ... drawbacks become better defined. Resistance testing is used ...
... Bill Ledger, of Sheffield University has developed a test, which ... woman has left//. ,The test, which is expected ... fertility is dropping off. The development has been hailed to ... give women the same control over their fertility as the ...
... of Oxford, UK has found a new theory from the ... administered world wide for children’s to prevent// from Tuberculosis infection ... with TB infection. The researchers studied the risk factors involved ... had BCG scar, as the absence of BCG scar implies ...
... teeth and gums are photosensitive says an article published ... The paper authored by a researcher at Washington University// ... is an important factor in the maintenance of oral ... to oral health," observed study author Charles F. Hildebolt, ...
... (ED) is the inability of a man to achieve or ... needs of his partner. Most men experience this at some ... not psychologically affected by it. Some men, however, experience chronic, ... ,According to a new study in the October 18 ...
... fish has been proved with evidence following the finding that ... of three to four years. The research adds to the ... sharp//. ,Previous findings have established that consumption of ... Alzheimer’s disease and stroke. Fish such as salmon and tuna ...
Cached Medicine News:Health News:Simplest therapeutic regimen found less effective against HIV 2Health News:Women can now gauge their own future fertility 2Health News:BCG vaccine for both Protection and treatment of Tuberculosis 2Health News:Sunlight For Healthy Gums And Teeth 2Health News:Erectile dysfunction: an early warning sign of clinically silent coronary artery disease? 2
... fixed pipette is ideal for ... volume. Fixed volume FInnpipettes offer ... as other Finnpipette Digital pipettes: ... blow-out (1-40ul), Soft-touch tip ejection, ...
500L...
... ergonomics, and value!, Comfortable feel ... non-slip, contoured handle , Finer control ... spring action , Completely autoclavable for ... need for recalibration , Easy-to-read precision ...
Pipetman F is a fixed-volume, air-displacement pipette. Thirteen robust models cover a large volume range from 2 L to 1000 L, with Gilsons legendary accuracy and precision....
Medicine Products: